Feedback    Advertise    Submit Papers    Reprints    About    Help    Contact   
Upstream Processing Downstream Processing Manufacturing Analytical Facilities
Archive by Issue Archive by Article Type Supplements
CMC Forum Press Releases
Eshmuno™ Resins for Biochromatography
Jessica Schrampf
BioProcess International, Vol. 8, No. 7, July–August 2010, p. 70
 



Eshmuno™ is a new and unique family of ion-exchange resins that are designed specifically for highly productive downstream bioprocessing. The first member of the family, Eshmuno™ S, is a smart cation exchanger designed for fast and efficient purification of antibodies in direct capture and steps following protein A chromatography. Eshmuno™ Q is the newest family member. This smart anion-exchange resin coupled Merck KGaA's renowned tentacle structure with the new hydrophilic polyvinyl ether base matrix. As a result, Eshmuno™ Q offers outstanding results in typical anion-exchange applications, such as removing impurities in flow-through mode or separating blood factors in plasma processing.

Superior Productivity for Biomolecule Purification

Eshmuno™ Q exhibits a superior binding capacity for various biomolecules. Figure 1 shows the dynamic binding capacity (DBC) of Eshmuno™ Q for selected macromolecules at different flow rates. High flow rates (2 minutes residence time correspond to ~600 cm/hour) do not affect the high binding capacities at low flow rates.



More Stability

Unlike conventional anion-exchange resins, Eshmuno™ Q is intrinsically stable against alkaline solutions used in column sanitization. Figure 2 shows the increased stability of Eshmuno™ Q during storage in 1 M sodium hydroxide solution. Eshmuno™ Q retains its high binding capacity, whereas other anion-exchange resins suffer considerable reductions.



Tangible Savings in Cost and Development Time

Eshmuno™ Q showed remarkably sharp elution of the target molecule in a wide range of applications. Figure 3 shows the elution profile of purified MAb03 at pH 9.5 with 2 minutes residence time (CV = 1 mL), compared with the profile of another surface-grafted anion exchanger. Eshmuno™ Q elutes the antibody in a sharp peak of 12.4 mL; the other resin's eluate volume is 27.6 mL.



The 130% higher concentration of the target molecule and the 60% reduced elution volume render further concentration steps unnecessary, saving money on buffer solutions and consumables. Our Global Applied Technology Department supports Eshmuno™ users with a global network of applications centers on three continents and with renowned training programs.

Author Details
Jessica Schrampf is marketing manager for LSS, 480 South Democrat Rd, Gibbstown NJ 08027; 1-856-423-6300; jessica.schrampf@emdchemicals.com; www.emdchemicals.com.

 
| | Share
Biopharmaceutical Production
Facility Design Strategies for Single-Use Technologies

Please join us for a free webinar addressing strategies for facility design in biopharmaceutical manufacturing:

Wednesday, 29 February 2012
8:00 AM and 1:00 PM EST

Presented by:

Ingrid Long, MSc
Research Engineer
GE Healthcare Life Sciences

Register today!

During the webinar, Ms. Long will discuss the impact of different strategies for facility design, with a focus on the following topics:

* Replacement of traditional equipment with the single-use equivalent
* Biopharmaceutical manufacturing in a single room
* Benefits of facility design with respect to cost, risk, and flexibility

Register today!


Nine Conferences — One Location: Hilton Bayfront (San Diego, CA)
Webinars   
Subscribe   
Reprints   
Contact   
About   
Informa plc
©2002 - 2009 BioProcess International
Ph: 508-616-5550